<DOC>
	<DOCNO>NCT00318461</DOCNO>
	<brief_summary>This trial conduct Europe , Oceania , Africa , Asia South America . This trial design show effect treatment liraglutide add exist metformin therapy compare effect metformin monotherapy combination therapy metformin glimepiride . Two trial period : A 6 month ( 26 week ) randomise , double-blinded period follow 18 month open-label extension , total 2 year ( 104 week ) .</brief_summary>
	<brief_title>To Compare Effect Liraglutide When Given Together With Metformin With Effect Metformin Given Alone With Effect Glimepiride Metformin Given Together</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Subjects diagnose type 2 diabetes treat oral antidiabetic drug ( OADs ) least 3 month HbA1c : 7.011.0 % ( incl . ) subject OAD monotherapy . 7.010.0 % ( incl . ) subject OAD combination therapy Body Mass Index ( BMI ) less equal 40 kg/m2 Subjects treat insulin within last three month Subjects serious medical condition Females child bear potential pregnant , breastfeed intention become pregnant use adequate contraceptive method Subjects use drug ( except OADs ) , Investigator 's opinion could interfere glucose level ( e.g . systemic corticosteroid )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>